On November 6, the US EPA established MRLs for spirotetramat and imazapyr.
Objections and requests for hearings for these changes must be received on or before January 6, 2014.
Relevant changes have been made to www.mrldatabase.com.
Brazil's National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA) recently published public consultation document Consulta Pública n° 5, de 27 de Março de 2013 (in Portuguese). This proposal includes a draft MRL for the active ingredient imazapyr on soy.